Korean J Gastroenterol.  2019 Oct;74(4):193-196. 10.4166/kjg.2019.74.4.193.

Second Primary Cancer after Treating Gastrointestinal Cancer

Affiliations
  • 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. SENSASS@yuhs.ac

Abstract

Advances in diagnosis and therapeutic technologies have brought increased life expectancy for most cancers, but paradoxically it also has increased the risk of second primary malignancies. Cancer survivors have a higher risk of developing cancer than the general population. This suggests that more studies are needed to develop screen and management programs for cancer survivors, especially patients with gastrointestinal cancers, which are the most common cancers in Korea.

Keyword

Neoplasms; Secondary primary; Gastrointestinal neoplasms

MeSH Terms

Diagnosis
Gastrointestinal Neoplasms*
Humans
Korea
Life Expectancy
Neoplasms, Second Primary*
Survivors

Figure

  • Fig. 1 Five-year survival rates (%) of cancer at all sites, stomach, colon, liver, and bile duct according to the year of diagnosis from 1993 to 2016 in Korea.4


Reference

1. Chung JW, Chung MJ, Bang S, et al. Assessment of the risk of colorectal cancer survivors developing a second primary pancreatic cancer. Gut Liver. 2017; 11:728–732.
Article
2. Dong C, Hemminki K. Second primary neoplasms in 633,964 cancer patients in Sweden, 1958-1996. Int J Cancer. 2001; 93:155–161.
Article
3. Tabuchi T, Ito Y, Ioka A, Miyashiro I, Tsukuma H. Incidence of metachronous second primary cancers in Osaka, Japan: update of analyses using population-based cancer registry data. Cancer Sci. 2012; 103:1111–1120.
Article
4. Jung KW, Won YJ, Kong HJ, Lee ES. Cancer Statistics in Korea: incidence, mortality, survival, and prevalence in 2016. Cancer Res Treat. 2019; 51:417–430.
Article
5. Shin DW, Cho B, Kim SY, Jung JH, Park JH. Management of cancer survivors in clinical and public health perspectives: current status and future challenges in Korea. J Korean Med Sci. 2013; 28:651–657.
Article
6. Curtis RE, Freedman DM, Ron E. New malignancies among cancer survivors: SEER cancer registries, 1973–2000. Bethesda (MD): National Cancer Institute;2006.
7. Dong C, Hemminki K. Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958–1996: a search for common mechanisms. Br J Cancer. 2001; 85:997–1005.
Article
8. Morais S, Antunes L, Bento MJ, Lunet N. Risk of second primary cancers among patients with a first primary gastric cancer: a population-based study in North Portugal. Cancer Epidemiol. 2017; 50(Pt A):85–91.
Article
9. Guan X, Jin Y, Chen Y, et al. The incidence characteristics of second primary malignancy after diagnosis of primary colon and rectal cancer: a population based study. PLoS One. 2015; 10:e0143067.
Article
10. Nielsen SF, Nordestgaard BG, Bojesen SE. Associations between first and second primary cancers: a population-based study. CMAJ. 2012; 184:E57–E69.
Article
11. Jo JH, Cho IR, Jung JH, et al. Clinical characteristics of second primary pancreatic cancer. PLoS One. 2017; 12:e0179784.
Article
12. Lee JE, Shin DW, Lee H, et al. One-year experience managing a cancer survivorship clinic using a shared-care model for gastric cancer survivors in Korea. J Korean Med Sci. 2016; 31:859–865.
Article
13. Jung HY. Current status of endoscopic resection of early gastric cancer in Korea. Korean J Gastroenterol. 2017; 70:121–127.
Article
14. Shah BK, Khanal A, Hewett Y. Second primary malignancies in adults with gastric cancer - a US population-based study. Front Oncol. 2016; 6:82.
Article
15. Chen SC, Liu CJ, Hu YW, et al. Second primary malignancy risk among patients with gastric cancer: a nationwide population-based study in Taiwan. Gastric Cancer. 2016; 19:490–497.
Article
16. Kim C, Chon H, Kang B, et al. Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer. BMC Cancer. 2013; 13:394.
Article
17. Kim JW, Jang JY, Chang YW, Kim YH. Clinical features of second primary cancers arising in early gastric cancer patients after endoscopic resection. World J Gastroenterol. 2015; 21:8358–8365.
Article
18. Kim JY, Jang WY, Heo MH, et al. Metachronous double primary cancer after diagnosis of gastric cancer. Cancer Res Treat. 2012; 44:173–178.
Article
19. Phipps AI, Chan AT, Ogino S. Anatomic subsite of primary colorectal cancer and subsequent risk and distribution of second cancers. Cancer. 2013; 119:3140–3147.
Article
20. Lee YT, Liu CJ, Hu YW, et al. Incidence of second primary malignancies following colorectal cancer: a distinct pattern of occurrence between colon and rectal cancers and association of co-morbidity with second primary malignancies in a population-based cohort of 98,876 patients in Taiwan. Medicine (Baltimore). 2015; 94:e1079.
21. Dasgupta P, Youlden DR, Baade PD. Multiple primary cancers among colorectal cancer survivors in Queensland, Australia, 1996-2007. Cancer Causes Control. 2012; 23:1387–1398.
Article
22. Yun HR, Yi LJ, Cho YK, et al. Double primary malignancy in colorectal cancer patients--MSI is the useful marker for predicting double primary tumors. Int J Colorectal Dis. 2009; 24:369–375.
Article
23. Wu WC, Chen YT, Hwang CY, et al. Second primary cancers in patients with hepatocellular carcinoma: a nationwide cohort study in Taiwan. Liver Int. 2013; 33:616–623.
Article
24. Zhuang L, Yan X, Meng Z. Second primary malignancy in patients with cholangiocarcinoma: a population-based study. Cancer Manag Res. 2019; 11:1969–1983.
25. Shin DW, Baik YJ, Kim YW, et al. Knowledge, attitudes, and practice on second primary cancer screening among cancer survivors: a qualitative study. Patient Educ Couns. 2011; 85:74–78.
Article
26. Shin DW, Cho J, Yang HK, et al. Oncologists' experience with patients with second primary cancer and the attitudes toward second primary cancer screening: a nationwide survey. Cancer Res Treat. 2015; 47:600–606.
Article
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr